» Articles » PMID: 34454005

Weight Gain Following Pancreas Transplantation in Type 1 Diabetes is Associated with a Worse Glycemic Profile: A Retrospective Cohort Study

Abstract

Aims: Evaluate the weight trajectories after pancreas transplantation (PT) and their relationships with pancreas graft outcomes in type 1 diabetes (T1D).

Methods: Retrospective cohort study. T1D individuals who underwent PT were recruited (T1D-PT; n = 194) and divided into three groups according to transplantation date: 1999-2004 (n = 57), 2005-2009 (n = 79), 2010-2015 (n = 58). For weight comparisons, a random sample of T1D without renal impairment was also recruited during 2015 (n = 61; T1D-control).

Results: The median follow-up for the T1D-PT group was 11.1 years. Despite significant weight loss at 6 months (65.7 ± 12.4 vs. 64.1 ± 11.4 Kg; p < 0.001), a stepped increase was seen thereafter (60 months: 68.0 ± 14.0 Kg; p < 0.001). Participants from the 2010-2015 period showed higher weight gain (p < 0.001), outweighing that observed in the T1D-control (60 months: +4.69 ± 8.49 vs. -0.97 ± 4.59 Kg; p = 0.003). Weight gain between 6 and 36 months was directly associated with fasting glucose and HbA1c at 36 months, and with HbA1c at 60 months (p < 0.05). However, in Cox-regression models adjusted for age, sex, and several recipient and PT-related variables, the third tertile of weight gain between 6 and 36 months showed a non-significant increase in the graft failure/dysfunction (HR 2.33 [0.75-7.27]).

Conclusions: Weight gain post-PT was associated with glucose-related biochemical markers of graft dysfunction, which needs confirmation in further studies.

Citing Articles

Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation.

Boswell L, Amor A, Montagud-Marrahi E, Casals G, Diaz-Catalan D, Banon-Maneus E Diabetes Ther. 2023; 15(1):165-181.

PMID: 37917327 PMC: 10786804. DOI: 10.1007/s13300-023-01487-1.


Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal".

Kataoka H, Nitta K, Hoshino J Front Med (Lausanne). 2023; 10:1179834.

PMID: 37521339 PMC: 10372422. DOI: 10.3389/fmed.2023.1179834.


Metabolic Outcomes After Pancreas Transplant Alone From Donation After Circulatory Death Donors-The UK Transplant Registry Analysis.

Gopal J, McLean A, Muthusamy A Transpl Int. 2023; 36:11205.

PMID: 37266028 PMC: 10229791. DOI: 10.3389/ti.2023.11205.


Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas-Kidney Transplantation: Time in Range and Glucose Variability.

Dmitriev I, Severina A, Zhuravel N, Yevloyeva M, Salimkhanov R, Shchelykalina S Diagnostics (Basel). 2023; 13(9).

PMID: 37174997 PMC: 10177867. DOI: 10.3390/diagnostics13091606.